基于CRISPR/Cas12a和杂交连锁反应的快速和裸眼的甲基西林耐药黄金葡萄球菌查方法
Yayun Jiang1, Zongyao Chen2, Xiao Liu2
1Digestive Diseases Center, Deyang People's Hospital, Chengdu University of Traditional Chinese Medicine, Deyang, Sichuan, China.
Frontiers in microbiology
|July 31, 2025
概括
一种名为MCFHCR的新方法,使用Cas12a和光,快速检测出耐甲黄金葡萄球菌 (MRSA). 这种视觉检测比目前的技术更快,更简单,为MRSA诊断提供了一个有前途的工具.
科学领域:
- 生物技术是生物技术.
- 分子诊断学 分子诊断
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 甲素耐药黄金葡萄球菌 (MRSA) 是一个主要的全球健康威胁,由于其广泛的耐药性.
- 现有的MRSA检测方法,如培养和核酸测定,通常是缓慢的,需要专门的设备,阻碍了快速诊断.
研究的目的:
- 开发一种快速,可视和敏感的MRSA检测方法.
- 克服目前MRSA检测诊断技术的局限性.
主要方法:
- 开发了一种新的方法 (MCFHCR),将ssDNA功能化的磁珠,Cas12a跨裂变活性和杂化链反应 (HCR) 结合起来进行信号放大.
- 使用一个信号关闭的光平台,其中目标的存在使HCR失效并减少光.
- 与复合酶聚合酶放大 (RPA) 集成,以提高灵敏度和速度.
主要成果:
- MCFHCR的检测极限为mecA DNA的5个副本/μL,MRSA的8个CFU/mL.
- 测试在35分钟内完成,显示了显著的速度改善.
- 检测临床MRSA菌株的性能与定量PCR (qPCR) 和药物敏感性测试相美.
结论:
- MCFHCR提供了一种简单,快速和可视检测的MRSA检测方法.
- 该测试显示了高灵敏度和与已知方法相比较的准确性.
- 在临床环境中,MCFHCR具有重要的实际应用潜力,可及时诊断MRSA.
相关概念视频
CRISPR/Cas9 Genome Editing
252
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
252
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K


